explore -WSS

explore

author：comprehensive 2025-09-30 00:02:55 - browse：2

Slayman with (left to right) Dr. Leo Riella, Medical Director of Kidney Transplantation, Dr. Nahel Elias, Interim Chief, Division of Transplant Surgery, his partner, Faren, and Dr. Tatsuo Kawai, Director, Legorreta Center for Clinical Transplant Tolerance. -- HEALTH coverage from STAT — Rick Slayman, holding hands with his partner, Faren, poses with members of his Massachusetts General Hospital medical team before being going home last month. Michelle Rose/Massachusetts General Hospital

Rick Slayman, the first man to receive a kidney transplant from a genetically engineered pig, has died, according to a statement from his family and Massachusetts General Hospital, where he underwent the historic operation in March.

“Our family is deeply saddened about the sudden passing of our beloved Rick but take great comfort knowing he inspired so many,” his family said in the statement released Saturday evening.

The hospital did not say how or when Slayman died. A spokesperson declined to provide further information, citing “privacy issues.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Colonoscopy at 40? Study finds a possible benefit

leisure time

WSS

Ask STAT: What do you want to know about ChatGPT in medicine?

Why are elite athletes different? Take a look at their microbes

New guidelines on severe brain injury complicate already difficult decisions

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

Colonoscopy at 40? Study finds a possible benefit

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

hotspot

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Wikipedia

Peter Hotez and the public health issue of online harassment

Alabama hospital puts IVF treatments on hold

ChatGPT in medicine: STAT answers readers' burning questions

Medicare inequities exacerbate Puerto Rico’s health disparities

Medical leaders decry Supreme Court decision on affirmative action

The strategy behind pharma's lawsuits over drug pricing reform

Tori Bowie and the unacceptable rates of Black maternal death

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

Continuity nursing helped my family in our darkest PICU moments

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

hotspot

In utero gene editing: an explainer

Ask STAT: What do you want to know about ChatGPT in medicine?

The story of mRNA: From a loose idea to a tool that may help curb Covid

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

The story of mRNA: From a loose idea to a tool that may help curb Covid

PBM reform efforts get punted in Congress

hotspot

hotspot

leisure time

hotspot